Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis.
about
Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@ast
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@en
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@nl
type
label
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@ast
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@en
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@nl
prefLabel
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@ast
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@en
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@nl
P2093
P2860
P1433
P1476
Standard chemotherapy is super ...... kin lymphoma: a meta-analysis.
@en
P2093
Jian Ouyang
Rongfu Zhou
Yonggong Yang
P2860
P2888
P304
P356
10.1007/S12032-010-9517-0
P50
P577
2010-04-06T00:00:00Z
P6179
1026736439